Prince Ntiamoah, MD
Pulmonary Disease · Green Bay, WINPI 1043731706
Payments from drug & device makers
What this record shows
This record is dominated by grants: $30,000 of the $36,768 with a category attached, or 81.6%. Boston Scientific accounts for 81.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $20,792 and has fallen 98.0% since, to $422 in 2025. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $1267.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$30K
- Intuitive Surgical$5K
- Noah Medical Corporation$790
- Pulmonx Corporation$397
- AstraZeneca$220
- Steris Corporation$158
- plus $273 from 3 others
What the payments were for
- Grants$30,00082%
- Travel & lodging$2,2986%
- Food & beverage$1,9705%
- Education$2,5007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $30,025 |
| Intuitive Surgical | 13 | $4,906 |
| Noah Medical Corporation | 1 | $790 |
| Pulmonx Corporation | 4 | $397 |
| AstraZeneca | 2 | $220 |
| Steris Corporation | 1 | $158 |
| Johnson & Johnson | 2 | $121 |
| Olympus America Inc. | 1 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,768 in reported general payments places this provider in the 95th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 18 | $56 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Green Bay
- Manar Al ShahrouriGreen Bay$61K
- Musab NusratGreen Bay$12K
- Jeremy RenzGreen Bay$10K
- Fazal RaziqGreen Bay$8K
- Raul Mendoza AyalaGreen Bay$7K
- Ramya GorthiGreen Bay$6K
- Pamela SudGreen Bay$4K
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Hasnain BawaadamKenosha$686K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.